Literature DB >> 12915449

Growth retardation and skin abnormalities of the Recql4-deficient mouse.

Yuko Hoki1, Ryoko Araki, Akira Fujimori, Tatsuya Ohhata, Haruhiko Koseki, Ryutaro Fukumura, Miki Nakamura, Hirokazu Takahashi, Yuko Noda, Seiji Kito, Masumi Abe.   

Abstract

Mutations in the Recql4 gene are very likely responsible for a subset of Rothmund-Thomson syndrome (RTS) cases, but until now there has been no animal model to confirm this. Knockout mice in which the Recql4 gene is disrupted at exons 5-8 exhibit embryonic lethality at embryonic day 3.5-6.5. We generated a helicase activity-inhibited mouse by deleting exon 13 of Recql4, which is one of the coding exons of the consensus RecQ-helicase domain. This domain is the primary site of mutations that have been identified in RTS patients. The exon 13-deleted Recql4-deficient mice are viable, but exhibit severe growth retardation and abnormalities in several tissues, and embryonic fibroblasts show a defect in cell proliferation. Abnormalities in the Recql4-deficient mice are similar to those in RTS patients, suggesting that defects in the Recql4 gene may indeed be responsible for RTS. We speculate that the loss of Recql4 helicase activity results in the prematurely aged appearance observed in some RecQ helicase diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915449     DOI: 10.1093/hmg/ddg254

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  43 in total

1.  The N-terminal noncatalytic region of Xenopus RecQ4 is required for chromatin binding of DNA polymerase alpha in the initiation of DNA replication.

Authors:  Kumiko Matsuno; Maya Kumano; Yumiko Kubota; Yoshitami Hashimoto; Haruhiko Takisawa
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

2.  Dual DNA unwinding activities of the Rothmund-Thomson syndrome protein, RECQ4.

Authors:  Xiaohua Xu; Yilun Liu
Journal:  EMBO J       Date:  2009-01-29       Impact factor: 11.598

Review 3.  The RecQ DNA helicases in DNA repair.

Authors:  Kara A Bernstein; Serge Gangloff; Rodney Rothstein
Journal:  Annu Rev Genet       Date:  2010       Impact factor: 16.830

4.  Ribosomal Protein S3 Negatively Regulates Unwinding Activity of RecQ-like Helicase 4 through Their Physical Interaction.

Authors:  Ajay Vitthal Patil; Tao-Shih Hsieh
Journal:  J Biol Chem       Date:  2017-02-03       Impact factor: 5.157

5.  Direct and indirect roles of RECQL4 in modulating base excision repair capacity.

Authors:  Shepherd H Schurman; Mohammad Hedayati; ZhengMing Wang; Dharmendra K Singh; Elzbieta Speina; Yongqing Zhang; Kevin Becker; Margaret Macris; Patrick Sung; David M Wilson; Deborah L Croteau; Vilhelm A Bohr
Journal:  Hum Mol Genet       Date:  2009-06-29       Impact factor: 6.150

Review 6.  Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.

Authors:  Yu-Hsuan Lin; Brittany E Jewell; Julian Gingold; Linchao Lu; Ruiying Zhao; Lisa L Wang; Dung-Fang Lee
Journal:  Trends Mol Med       Date:  2017-07-20       Impact factor: 11.951

7.  Disruption of Supv3L1 damages the skin and causes sarcopenia, loss of fat, and death.

Authors:  Erin Paul; Rachel Cronan; Paula J Weston; Kim Boekelheide; John M Sedivy; Sang-Yun Lee; David L Wiest; Murray B Resnick; Jan E Klysik
Journal:  Mamm Genome       Date:  2009-01-15       Impact factor: 2.957

Review 8.  Rothmund-Thomson syndrome.

Authors:  Lidia Larizza; Gaia Roversi; Ludovica Volpi
Journal:  Orphanet J Rare Dis       Date:  2010-01-29       Impact factor: 4.123

9.  The Rothmund-Thomson syndrome helicase RECQL4 is essential for hematopoiesis.

Authors:  Monique F Smeets; Elisabetta DeLuca; Meaghan Wall; Julie M Quach; Alistair M Chalk; Andrew J Deans; Jörg Heierhorst; Louise E Purton; David J Izon; Carl R Walkley
Journal:  J Clin Invest       Date:  2014-06-24       Impact factor: 14.808

10.  dRecQ4 is required for DNA synthesis and essential for cell proliferation in Drosophila.

Authors:  Yanjuan Xu; Zhiyong Lei; Hai Huang; Wen Dui; Xuehong Liang; Jun Ma; Renjie Jiao
Journal:  PLoS One       Date:  2009-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.